<DOC>
	<DOCNO>NCT00396929</DOCNO>
	<brief_summary>The aim study examine efficacy Paclitaxel injection stent implantation patient stenosis native coronary artery prevent restenosis comparision two admitted therapy .</brief_summary>
	<brief_title>Efficiency New Therapy Treat Stenosis Coronary Vessels Comparison With Two Already Admitted Therapies</brief_title>
	<detailed_description>The aim study examine whether patient stable instable Angina pectoris and/or document myocardial ischemia presence de-novo stenosis native coronary artery degree stenosis 50 % 99 % additional local administration paclitaxel implantation conventional stent superior implantation conventional stent alone respect late lumen loss ( LLL ) . In case superiority examine whether additional local administration paclitaxel implantation conventional stent inferior implantation paclitaxel-eluting stent respect late lumen-luss . Is case , superiority test .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>age : 18 80 , male female stable instable angina pectoris or/ document myocardial ischemia willingness ability adhere study condition write informed consent patient information Denovo stenosis coronary artery degree stenosis 50 % 99 % , accessible PTCA Target vessel diameter least 2,5 mm length lesion 18 mm Acute myocardial infarction still elevate CK/CKMB acute myocardial infarction know severe arrhythmia necessitate long term antiarrhythmic therapy pericarditis intracardiac thrombus Bacterial endocarditis Cardiopulmonary reanimation cardiac massage within last 6 month Thromboembolic accident within last 6 month Severe peripheral arterial occlusive disease , exclude use 6 French catheter require special antithrombotic anticoagulatory regime Manifest hyperthyreosis Neutrohile granulocytes less 3000/mm3 platelet 100.000 700.000/mm3 Renal insufficiency serum creatinine 1,5 mg/L severe systemic hypertension despite antihypertensive medication disease might lead protocol violation reduce life expectancy significant upper intestinal bleeding within last 6 month life expectancy &lt; 1 year poor general condition Premenopausal woman , woman postmenopausal less 2 year know allergy hypersensitivity Paclitaxel , one TAXOLcomponents , one stent component , acetylsalicylic acid , heparin , clopidogrel contrast agent Concurrent participation participation within last 30 day prior screen another drug trial trial medical device absence write declaration consent inability , understand sense purpose study willing keep condition study Bifurcation stenosis , ostium stenosis , main stem stenosis ot target vessel visible thrombus target vessel Severely curve sclerosed target vessel complete closure target vessel Severe impairment leave ventricular function leave ventricular ejection fraction le 30 % Patients expect indication operative myocardial revascularisation within next six month patient contraindication aortocoronary bypass operation , patient , principally available second coronary angiography 6 month stent implantation contraindication second coronary angiography</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Paclitaxel</keyword>
	<keyword>Restenosis</keyword>
	<keyword>Stent</keyword>
	<keyword>Intracoronary Dosis</keyword>
	<keyword>Paclitaxel-eluting Stent</keyword>
</DOC>